Targeted Inhibition of the DNA Damage Response Pathway: A Novel Intervention in the Treatment of Pediatric Leukemias |
National Cancer Institute / Andre Nussenzweig, Ph.D. |
Reach Grants |
2014 |
Maryland |
Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia |
National Cancer Institute / Christopher Chien, PhD |
Young Investigator Grants |
2014 |
Maryland |
Ca2+ Release Activated Ca2+ (CRAC) Channels in Control of Leukemic Cell Metabolism and Leukemia Stem Cell Maintenance in T-ALL |
New York University School of Medicine / Mate Maus, PhD |
Young Investigator Grants |
2014 |
New York |
Targeting the Accomplices of MYC in MYC-driven Medulloblastoma |
Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, Ph.D. |
Innovation Grants |
2014 |
California |
APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition? |
Children’s Hospital of Philadelphia / Abby Green, MD |
Young Investigator Grants |
2014 |
Pennsylvania |
The Tumor Suppressive Role of LNK (SH2B3) in Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Wei Tong, PhD |
Innovation Grants |
2014 |
Pennsylvania |
Trk-Targeted Therapy of Human Neuroblastomas |
Children’s Hospital of Philadelphia / Garrett Brodeur, M.D. |
Bridge Grants |
2014 |
Pennsylvania |
Hospital Volume and Induction Mortality in Children, Adolescents, and Young Adults with Acute Leukemia |
Children’s Hospital of Philadelphia / Jennifer Wilkes, MD |
Young Investigator Grants |
2014 |
Pennsylvania |
Modeling Juvenile Myelomonocytic Leukemia with Patient-Derived Induced Pluripotent Stem Cells |
Children’s Hospital of Philadelphia / Mitchell Weiss, M.D., Ph.D. |
Innovation Grants |
2014 |
Pennsylvania |
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD |
Young Investigator Grants |
2014 |
Maryland |